Search Results - "Kobierska, A."

Refine Results
  1. 1

    Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix by van Luijk, I.F., Coens, C., van der Burg, M.E.L., Kobierska, A., Namer, M., Lhomme, C., Zola, P., Zanetta, G., Vermorken, J.B.

    Published in Annals of oncology (01-02-2007)
    “…Objective: We carried out a phase II trial with BEMP [bleomycin, vindesine (Eldisine®), mitomycin C and cisplatin] in patients with recurrent and/or metastatic…”
    Get full text
    Journal Article
  2. 2

    A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin by Vermorken, J. B., Kobierska, A., Chevallier, B., Zanaboni, F., Pawinski, A., Bolis, G.

    Published in Annals of oncology (01-08-2000)
    “…Background In vitro data demonstrated a dose-response relationship for doxorubicin in ovarian cancer cell lines. However, this dose-response question for…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group by Aapro, M.S, van Wijk, F.H, van der Burg, M.E.L, ten Bokkel Huinink, W, Vergote, I, Guastalla, J.P, Rosso, R, Kobierska, A, Beex, L.V.A, Namer, M, Splinter, T.E.W, Vermorken, J.B

    Published in European journal of cancer (1990) (01-05-2003)
    “…30 patients with advanced ovarian cancer, all platinum pretreated, were treated with an induction cycle of fotemustine. Maintenance therapy was given to 6…”
    Get full text
    Journal Article
  6. 6

    Sarcoma of the uterus. A clinical study of 42 patients by Jereczek, B, Jassem, J, Kobierska, A

    “…Records of 42 patients with a diagnosis of uterine sarcoma treated between 1974 and 1995 at the Department of Oncology and Radiotherapy, Medical University of…”
    Get full text
    Journal Article
  7. 7

    Influence of brachytherapy applicators geometry on dose distribution in cervical cancer by SENKUS-KONEFKA, E, KOBIERSKA, A, JASSEM, J, SERKIES, K, BADZIO, A

    Published in Strahlentherapie und Onkologie (01-06-1997)
    “…Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications…”
    Get full text
    Journal Article
  8. 8

    Phase I study of high-dose epirubicin in platinum-pretreated patients with ovarian carcinoma by Vermorken, J B, ten Bokkel Huinink, W W, Kobierska, A, van der Burg, M E, Forni, M, Piccart, M J, van der Putten, E

    Published in Oncology (01-01-1999)
    “…In vitro data demonstrated a dose-response relationship for doxorubicin in ovarian cancer (OC) cell lines. However, this dose-response question for doxorubicin…”
    Get more information
    Journal Article
  9. 9

    High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience by Vermorken, J B, Kobierska, A, van der Burg, M E, Chevallier, B, Zanaboni, F, ten Bokkel Huinink, W W, Forni, M, Pawinski, A, van der Putten, E, Bolis, G

    “…A dose-response relationship for doxorubicin in ovarian cancer (OC) cell lines has been demonstrated in vitro. However, this has never been carefully addressed…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer by van der Burg, Maria E.L, van Lent, Mat, Buyse, Marc, Kobierska, Anna, Colombo, Nicoletta, Favalli, Giuseppe, Lacave, Angel J, Nardi, Mario, Renard, Josette, Pecorelli, Sergio

    Published in The New England journal of medicine (09-03-1995)
    “…The value of cytoreductive surgery in the management of ovarian cancer has been debated for years. The reasons for cytoreductive surgery are manifold. Large…”
    Get full text
    Journal Article
  12. 12

    In vivo alanine/EPR dosimetry in daily clinical practice: a feasibility study by Ciesielski, Bartlomiej, Schultka, Katarzyna, Kobierska, Anna, Nowak, Renata, Peimel-Stuglik, Zofia

    “…The objective of this study was evaluation of accuracy of in vivo dosimetry using electron paramagnetic resonance (EPR) in alanine. Additionally, we aimed to…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Influence of alternating extremely low frequency ELF magnetic field on structure and function of pancreas in rats by Laitl-Kobierska, Anna, Cieślar, Grzegorz, Sieroń, Aleksander, Grzybek, Henryk

    Published in Bioelectromagnetics (01-01-2002)
    “…The aim of this study was to estimate the influence on ultrastructure and function of endocrine and excretoric part of pancreas in rats of extremely low…”
    Get full text
    Journal Article
  16. 16

    The feasibility study on continuous 7-day-a-week external beam irradiation in locally advanced cervical cancer: a report on acute toxicity by Serkies, Krystyna, Kobierska, Anna, Konopa, Krzysztof, Sawicki, Tomasz, Jassem, Jacek

    Published in Radiotherapy and oncology (01-11-2001)
    “…Purpose: To evaluate the feasibility and toxicity of continuous 7-day-a-week pelvic irradiation with no breaks between external beam irradiation and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group by Vermorken, J B, Kobierska, A, Chevallier, B, Zanaboni, F, Pawinski, A, Bolis, G

    Published in Annals of oncology (01-08-2000)
    “…In vitro data demonstrated a dose-response relationship for doxorubicin in ovarian cancer cell lines. However, this dose-response question for anthracyclines…”
    Get full text
    Journal Article
  19. 19

    298. Toxicity and survival following radical radiotherapy in bladder cancer patients – a single institution experience by Bednaruk-Młyński, E., Zaucha, R., Kobierska, A., Jassem, J.

    “…Bladder cancer is the second most common malignancy of the genitourinary tract. The efficacy of RT in more advanced disease or loco-regional recurrences is…”
    Get full text
    Journal Article
  20. 20